Pharmacokinetics and Safety of KRN7000 Following Intravenous Infusion of RGI-2001 in Allogeneic Transplant Patients

被引：0
|
作者：
Chen, Yi-Bin
Lee, Dana D.
Lane, Hayley
Smith, Steve
Ishii, Yasuyuki
Lekakis, Lazaros J.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Phase 2b study of alloHSCT patients receiving RGI-2001, an NKT cell activator, demonstrates safety and protection from acute GVHD, correlating with increased NKT cell number in patient blood
    Bui, Jack D.
    Lee, Calvin
    Caron, Christine
    Lee, Dana
    DeFilipp, Zachariah
    Chen, Yi-Bin
    CANCER RESEARCH, 2024, 84 (07)
  • [22] Relationship between intravenous (IV) busulfan pharmacokinetics (PK) and patient characteristics in allogeneic stem cell transplant patients.
    Simmons, Ashley Erickson
    Keisler, Meredith Deal
    Ivanova, Anastasia
    Rao, Kamakshi V.
    Shea, Thomas C.
    Walko, Christine Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Intravenous topiramate: Safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate
    Clark, Anne M.
    Kriel, Robert L.
    Leppik, Ilo E.
    White, James R.
    Henry, Thomas R.
    Brundage, Richard C.
    Cloyd, James C.
    EPILEPSIA, 2013, 54 (06) : 1106 - 1111
  • [24] Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer
    Raymond, E
    Alexandre, J
    Faivre, S
    Vera, K
    Materman, E
    Boni, J
    Leister, C
    Korth-Bradley, J
    Hanauske, A
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2336 - 2347
  • [25] Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection
    Chakraborty, Abhijit
    Roy, Sandip
    Loeffler, Juergen
    Chaves, Ricardo L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (01) : 151 - 158
  • [26] Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells
    Chen, Yi-Bin
    Efebera, Yvonne A.
    Johnston, Laura
    Ball, Edward D.
    Avigan, David
    Lekakis, Lazaros J.
    Bachier, Carlos R.
    Martin, Paul
    Duramad, Omar
    Ishii, Yasuyuki
    Han, Semi
    Jung, Yu-Jin
    Lee, Dana
    Kunkel, Lori
    Negrin, Robert S.
    Bui, Jack D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (04) : 625 - 634
  • [27] Donor Lymphocyte Infusion in Patients with Thalassemia Major Who Have Mixed Chimerism Following Allogeneic Stem Cell Transplant
    Abraham, Aby
    Sindhuvi, Eunice
    Korula, Anu
    Fouzia, N. A.
    Srivastava, Alok
    George, Biju
    Mathews, Vikram
    BLOOD, 2015, 126 (23)
  • [28] Donor Lymphocyte Infusion in Patients with Thalassemia Major who have Mixed Chimerism following Allogeneic Stem Cell Transplant
    Abraham, Aby
    Sindhuvi, Eunice
    Kotula, Anu
    Abubacker, Fouzia N.
    Srivastava, Alok
    George, Biju
    Mathews, Vikram
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S138 - S138
  • [29] PHARMACOKINETICS OF CYTOMEGALO-VIRUS SPECIFIC IGG ANTIBODY FOLLOWING INTRAVENOUS IMMUNOGLOBULIN IN BONE-MARROW TRANSPLANT PATIENTS
    RAND, KH
    HOUCK, H
    GANJU, A
    BABINGTON, RG
    ELFENBEIN, GJ
    BONE MARROW TRANSPLANTATION, 1989, 4 (06) : 679 - 683
  • [30] Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid™ in healthy volunteers and in patients with reduced pulmonary diffusing capacity
    Landmark, Kristin Eitrem
    Johansen, Per Wiik
    Johnson, Judith A.
    Johansen, Bjorn
    Uran, Steinar
    Skotland, Tore
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2008, 34 (03): : 494 - 501
12345